Deep Track Capital, LP 13D and 13G filings for Ambrx Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 10:19 am Sale |
2024-09-30 | 13G | Ambrx Biopharma Inc. AMAM |
Deep Track Capital, LP | 0 0.000% |
-3,710,412 (Position Closed) |
Filing |
| 2024-02-14 11:31 am Unchanged |
2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM |
Deep Track Capital, LP | 3,710,412 5.880% |
0 (Unchanged) |
Filing |
| 2023-11-02 4:09 pm Purchase |
2023-10-23 | 13G | Ambrx Biopharma Inc. AMAM |
Deep Track Capital, LP | 3,710,412 5.650% |
3,710,412 (New Position) |
Filing |